• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEODENT - JJGC S.A. CM TITAMAX EX ACQUA IMPLANT 3.5X17; ENDOSSEOUS DENTAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEODENT - JJGC S.A. CM TITAMAX EX ACQUA IMPLANT 3.5X17; ENDOSSEOUS DENTAL IMPLANT Back to Search Results
Catalog Number 140.665
Medical Device Problem Code Failure to Osseointegrate (1863)
Health Effect - Clinical Codes Failure of Implant (1924); Pain (1994); Tissue Damage (2104)
Date of Event 08/07/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Exemption number: e2015015.Instradent usa, inc is submitting the report on behalf of neodent - jjgc.
 
Event or Problem Description
The clinician reported that almost 5 months after the dental implant and abutment were placed in ada site 4 in the mouth, the implant did not achieve osseointegration.Clinician noted patient's pain, mobility and bruxism.The product will be forwarded to the manufacturer for investigation.There were no reported post-operative complications.
 
Additional Manufacturer Narrative
Exemption number: e2015015.Instradent usa, inc is submitting the report on behalf of neodent - jjgc.
 
Event or Problem Description
The clinician reported that almost 5 months after the dental implant and abutment were placed in ada site 4 in the mouth, the implant did not achieve osseointegration.Clinician noted patient's pain, mobility and bruxism.The product will be forwarded to the manufacturer for investigation.There were no reported post-operative complications.(b)(4).
 
Additional Manufacturer Narrative
Exemption number: e2015015.Instradent usa, inc is submitting the report on behalf of neodent - jjgc.
 
Event or Problem Description
The clinician reported that almost 5 months after the dental implant and abutment were placed in ada site 4 in the mouth, the implant did not achieve osseointegration.Clinician noted patient's pain, mobility and bruxism.The product will be forwarded to the manufacturer for investigation.There were no reported post-operative complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CM TITAMAX EX ACQUA IMPLANT 3.5X17
Common Device Name
ENDOSSEOUS DENTAL IMPLANT
Manufacturer (Section D)
NEODENT - JJGC S.A.
av. juscelino kubitschek de
oliveira, 3291 cic
curitiba PR 81270 -200
BR  81270-200
MDR Report Key8044048
Report Number3008261720-2018-05357
Device Sequence Number1379925
Product Code DZE
UDI-Device Identifier07899878016779
UDI-Public07899878016779
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K133592
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2018
Reporter Type Manufacturer
Report Source distributor,foreign
Initial Reporter Occupation Dentist
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/14/2019
Report Date (Section F) 10/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/21/2017
Device Catalogue Number140.665
Device Lot Number800180932
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/07/2019
Was the Report Sent to FDA? No
Distributor Facility Aware Date01/15/2019
Device Age2 MO
Event Location Other
Date Report to Manufacturer10/24/2018
Initial Date Received by Manufacturer 10/24/2018
Supplement Date Received by Manufacturer10/24/2018
01/07/2019
Initial Report FDA Received Date11/06/2018
Supplement Report FDA Received Date01/14/2019
01/15/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ABUTMENT REMOVAL; ABUTMENT REMOVAL; ABUTMENT REMOVAL; ABUTMENT REMOVAL
Outcome Attributed to Adverse Event Required Intervention;
Patient Age66 YR
-
-